Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body …

N Blagitko-Dorfs, P Schlosser, G Greve, D Pfeifer… - Leukemia, 2019 - nature.com
DNA methyltransferase inhibitors (DNMTi) approved for older AML patients are clinically
tested in combination with histone deacetylase inhibitors (HDACi). The mechanism of action …
被引用次数：84 相关文章

Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body …

N Blagitko-Dorfs, P Schlosser, G Greve… - …, 2019 - pubmed.ncbi.nlm.nih.gov
DNA methyltransferase inhibitors (DNMTi) approved for older AML patients are clinically
tested in combination with histone deacetylase inhibitors (HDACi). The mechanism of action …
[PDF] google.com

[PDF][PDF] Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene …

N Blagitko-Dorfs, P Schlosser, G Greve, D Pfeifer… - Leukemia, 2019 - drive.google.com
DNA methyltransferase inhibitors (DNMTi) approved for older AML patients are clinically
tested in combination with histone deacetylase inhibitors (HDACi). The mechanism of action …

[引用][C] Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene …

N Blagitko-Dorfs, P Schlosser, G Greve, D Pfeifer… - Leukemia, 2018 - cir.nii.ac.jp
Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors:
predominant synergistic gene downregulation associated with gene body demethylation | CiNii …

Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body …

N Blagitko-Dorfs, P Schlosser, G Greve, D Pfeifer… - Leukemia, 2018 - europepmc.org
DNA methyltransferase inhibitors (DNMTi) approved for older AML patients are clinically
tested in combination with histone deacetylase inhibitors (HDACi). The mechanism of action …